RESTASIS MULTIDOSE vs VERKAZIA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Attribute	RESTASIS MULTIDOSE	VERKAZIA
Rating	72/100	70/100
Pharmacy pays	~$52.85 /30	~$52.85 /30
Type	RX	RX
Active ingredient	CYCLOSPORINE	CYCLOSPORINE
Manufacturer	Abbvie	Harrow Eye
Dosage forms	Emulsion	Emulsion
Drug class	Calcineurin Inhibitor Immunosuppressant	Calcineurin Inhibitor Immunosuppressant
Boxed warning	None	None
Half-life	about 8.4 hours (range 5 to 18 hours)	about 8.4 hours (range 5 to 18 hours)
Treats	Rheumatoid Arthritis, Focal Segmental Glomerulosclerosis, Systemic Lupus Erythematosus	Rheumatoid Arthritis, Focal Segmental Glomerulosclerosis, Systemic Lupus Erythematosus

restasis multidose verkazia

Rating

72/100

70/100

Pharmacy pays

~$52.85 /30

Type

Active ingredient

CYCLOSPORINE

Manufacturer

Abbvie

Harrow Eye

Dosage forms

Emulsion

Drug class

Calcineurin Inhibitor Immunosuppressant

Boxed warning

None

Half-life

about 8.4 hours (range 5 to 18 hours)

Treats

Rheumatoid Arthritis, Focal Segmental Glomerulosclerosis, Systemic Lupus Erythematosus

Frequently asked questions

Which is better-rated, Restasis Multidose or Verkazia?

By our independent rating, Restasis Multidose scores higher — 3.6 vs 3.5 out of 5 for Verkazia. Ratings are based on FDA regulatory (recall-safety) data.

Which is cheaper, Restasis Multidose or Verkazia?

Pharmacies pay about the same to acquire either one — roughly $52.85 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Restasis Multidose and Verkazia?

Both Restasis Multidose and Verkazia share the active ingredient Cyclosporine.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.